CSIMarket
 


Remedent Inc   (REMI)
Other Ticker:  
 

Cumulative Remedent Inc 's Working Capital Ratio for Trailing Twelve Months Period

REMI's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth


Select the Comparisons : Select the Ratio:

REMI Working Capital Ratio for Trailing Twelve Months Period

(Dec 31 2020)
III. Quarter
(Sep 30 2020)
II. Quarter
(Jun 30 2020)
I. Quarter
(Mar 31 2020)
IV. Quarter
(Dec 31 2019)
III. Quarter
Y / Y Current Liabilities Growth 7.69 % 7.55 % 10.45 % 18.45 % 20.76 %
Y / Y Current Assets Growth -8.94 % -16.4 % -23.04 % 3.83 % -2.02 %
Working Capital Ratio for Trailing Twelve Months Period 0.24 0.25 0.27 0.29 0.3
Total Ranking # 4656 # 4533 # 4569 # 4840 # 4906
Seq. Current Liabilities Growth 0.29 % 1.42 % -0.66 % 6.57 % 0.17 %
Seq. Current Assets Growth -6.16 % 13.42 % -3.5 % -11.34 % -13.85 %


Working Capital Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2020
On the trailing twelve months basis Due to rise in Current Liabilities in the III. Quarter to $3 millions, average cumulative Working Capital Ratio for Trailing Twelve Months Period decreased to 0.24 below Remedent Inc average Working Capital Ratio for Trailing Twelve Months Period.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Medical Equipment & Supplies industry 186 other companies have achieved higher Working Capital Ratio for Trailing Twelve Months Period than Remedent Inc . While overall ranking remained unchanged compare to previous quarter at no. .

What is Working Capital Ratio?
More about REMI
Working Capital Ratio REMI in the most recent quarter
Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 187
Sector # 890
S&P 500 # 4520


Working Capital Ratio for Trailing Twelve Months Period Statistics
High Average Low
0.89 0.66 0.24
(Dec. 30, 2014)   (Dec 31 2020)




Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2020, within Medical Equipment & Supplies Industry Working Capital Ratio for Trailing Twelve Months Period
Non Invasive Monitoring Systems Inc  0.66 
Pavmed Inc   0.65 
Endologix Inc  0.64 
Neovasc Inc   0.54 
Biotricity Inc   0.53 
American International Holdings Corp   0.46 
H cyte Inc  0.44 
Vystar Corporation  0.41 
Vivos Inc  0.33 
Tearlab Corp  0.29 
Remedent Inc   0.25 
Sanuwave Health Inc   0.24 
Petvivo Holdings Inc  0.24 
Sigyn Therapeutics Inc   0.24 
Predictive Oncology Inc   0.22 
Odyssey Health Inc   0.21 
Vycor Medical Inc   0.21 
Legacy Ventures International Inc  0.14 
Titan Medical Inc  0.12 
Therapeutic Solutions International Inc   0.12 
Docgo Inc   0.11 
Prolung Inc   0.11 
United Health Products Inc   0.10 
Nutriband Inc   0.10 
Guided Therapeutics Inc   0.09 
Altair International Corp   0.08 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com